Skip to main content

LUP Student Papers

LUND UNIVERSITY LIBRARIES

Medical Patents and Access to Medicines- how to incentivize the search for new drugs

Al Suhairy, Hiba LU (2013) JURM02 20131
Department of Law
Abstract
The thesis deals with matters relating to neglected diseases and the lack of pharmaceutical R&D for the same diseases. Everybody is entitled to the right to health and subsequently the right to access to medicines, however not everyone has been receiving the benefits of this right. Currently there is an unsatisfying market-driven system, that can be changed by new and innovative approaches, such as differential pricing systems, prize funds and public-private partnerships.
Since there is no legally binding treaty on the issue of pharmaceutical corporate responsibility in regards to access to medicines, one must turn to voluntary measures such as soft-law and CSR, that can be very influential on the behavior of multinational enterprises,... (More)
The thesis deals with matters relating to neglected diseases and the lack of pharmaceutical R&D for the same diseases. Everybody is entitled to the right to health and subsequently the right to access to medicines, however not everyone has been receiving the benefits of this right. Currently there is an unsatisfying market-driven system, that can be changed by new and innovative approaches, such as differential pricing systems, prize funds and public-private partnerships.
Since there is no legally binding treaty on the issue of pharmaceutical corporate responsibility in regards to access to medicines, one must turn to voluntary measures such as soft-law and CSR, that can be very influential on the behavior of multinational enterprises, hence pharmaceutical companies. (Less)
Please use this url to cite or link to this publication:
author
Al Suhairy, Hiba LU
supervisor
organization
course
JURM02 20131
year
type
H2 - Master's Degree (Two Years)
subject
keywords
Access to medicines, medical patents, neglected diseases, soft-law, CSR
language
English
id
3802170
date added to LUP
2014-01-24 11:03:24
date last changed
2014-01-24 11:03:24
@misc{3802170,
  abstract     = {The thesis deals with matters relating to neglected diseases and the lack of pharmaceutical R&D for the same diseases. Everybody is entitled to the right to health and subsequently the right to access to medicines, however not everyone has been receiving the benefits of this right. Currently there is an unsatisfying market-driven system, that can be changed by new and innovative approaches, such as differential pricing systems, prize funds and public-private partnerships. 
Since there is no legally binding treaty on the issue of pharmaceutical corporate responsibility in regards to access to medicines, one must turn to voluntary measures such as soft-law and CSR, that can be very influential on the behavior of multinational enterprises, hence pharmaceutical companies.},
  author       = {Al Suhairy, Hiba},
  keyword      = {Access to medicines,medical patents,neglected diseases,soft-law,CSR},
  language     = {eng},
  note         = {Student Paper},
  title        = {Medical Patents and Access to Medicines- how to incentivize the search for new drugs},
  year         = {2013},
}